in the present study we have investigated the effect of a new compound , 1-benzylindazole-3-oxyacetic acid , bendazac ( bdz ) on the in vitro glycation of soluble proteins ( albumin and fibrinogen ) and isolated glomerular basement membrane ( gbm ) .
C0033684
proteins
C0001924
albumin